Bruising, or ecchymosis, is not listed as a common or characteristic side effect of semaglutide in the FDA-approved prescribing information
As biosimilar competition expands across TNF inhibitors, anti-VEGF biologics, and oncology supportive care, Cordavis-format co-branded private label products could generate incremental PBM segment revenue of $500 million to $1.5 billion annually by 2027, partly offsetting regulatory headwinds
Long-term Benefits: Strong Bones and Teeth: Vitamin D plays a critical role in calcium absorption, promoting healthy bone development and preventing osteoporosis in adults and rickets in children
Science-backed face and body skincare for the visible skin changes associated with rapid weight loss, including facial volume loss, crepey skin, loss of firmness, and dehydration